Immediate Versus Deferred Switching From a Boosted Protease Inhibitor–based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study | Zendy

José M. Gatell | Zendy; Lambert Assoumou | Zendy; Graeme Moyle | Zendy; Laura Waters | Zendy; Margaret Johnson | Zendy; Peré Domingo | Zendy; Julie Fox | Zendy; Estebán Martínez | Zendy; Hans-Jürgen Stellbrink | Zendy; Giovanni Guaraldi | Zendy; Mar Masiá | Zendy; Mark Gompels | Zendy; Christoph Stephan | Zendy; Éric Florence | Zendy; Stefan Eßer | Zendy; François Raffi | Zendy; Juergen Rockstroh | Zendy; Andrea Giacomelli | Zendy; Jaime H. Vera | Zendy; José I. Bernardino | Zendy; Alan Winston | Zendy; María Saumoy | Zendy; Julien Gras | Zendy; Christine Katlama | Zendy; Anton Pozniak | Zendy; Linos Vandekerckhove | Zendy; Els Caluwé | Zendy; Stéphane De Wit | Zendy; Coca Necsoi | Zendy; Maartje Van Frankenhuijsen | Zendy; F. Raffi | Zendy; Clotilde Allavena | Zendy; Véronique Reliquet | Zendy; Morane Cavellec | Zendy; Audrey Rodallec | Zendy; Thierry Le Tourneau | Zendy; J. Connault | Zendy; JeanMichel Molina | Zendy; Samuel Ferret | Zendy; Miresta Prévilon | Zendy; Yazdan Yazdanpanah | Zendy; Roland Landman | Zendy; Véronique Joly | Zendy; Adriana Pinto Martinez | Zendy; Fabienne Caby | Zendy; Nadine Ktorza | Zendy; Luminita Schneider | Zendy; Timo Wolf | Zendy; Gundolf Schüttfort | Zendy; JanChristian Wasmuth | Zendy; Carolynne SchwarzeZander | Zendy; Christoph Boesecke | Zendy; HansJürgen Stellbrink | Zendy; Christian Hoffmann | Zendy; Michael Sabranski | Zendy; Robert Jablonka | Zendy; Heidi Wiehler | Zendy; Georg M. N. Behrens | Zendy; Matthias Stoll | Zendy; Gerrit Ahrenstorf | Zendy; Giulia Nardini | Zendy; Barbara Beghetto | Zendy; Antonella D’Arminio Montforte | Zendy; Teresa Bini | Zendy; Viola Cogliandro | Zendy; Massimo Di Pietro | Zendy; Francesco Maria Fusco | Zendy; Massimo Galli | Zendy; Stefano Rusconi | Zendy; Paola Meraviglia | Zendy; Ana González-Cordón | Zendy; Berta Torres | Zendy; Pere Domingo | Zendy; Gràcia Mateo | Zendy; María Luisa Navarro Gómez | Zendy; Joaquin Portillo | Zendy; Esperanza Merino | Zendy; Sergio Reus | Zendy; Vicente Boix | Zendy; Félix Gutiérrez | Zendy; Sergio Padilla | Zendy; Bonaventura Clotet | Zendy; Eugènia Negredo | Zendy; Anna Bonjoch | Zendy; José L. Casado | Zendy; Sara Bañón-Escandell | Zendy; José Sabán | Zendy; Africa Duque | Zendy; Daniel Podzamczer | Zendy; Laura Acerete | Zendy; Juan GonzálezGarcía | Zendy; José Ramón Arribas | Zendy; Víctor Hontañón | Zendy; Nicole Pagani | Zendy; Margherita Bracchi | Zendy; Amanda Clarke | Zendy; Tanya Adams | Zendy; Celia Richardson | Zendy; Borja Mora-Peris | Zendy; Scott Mullaney | Zendy; Nahum de Esteban | Zendy; Ana Milinkovic | Zendy; Sarah Pett | Zendy; Juan Tiraboschi | Zendy; Mike Youle | Zendy; Chloe Orkin | Zendy; Simon Rackstraw | Zendy; James Hand | Zendy; Louise Jennings | Zendy; Jane Nicholls | Zendy; Sarah Johnston | Zendy

Open Access

Immediate Versus Deferred Switching From a Boosted Protease Inhibitor–based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study

Author(s) -

José M. Gatell,

Lambert Assoumou,

Graeme Moyle,

Laura Waters,

Margaret Johnson,

Peré Domingo,

Julie Fox,

Estebán Martínez,

Hans-Jürgen Stellbrink,

Giovanni Guaraldi,

Mar Masiá,

Mark Gompels,

Christoph Stephan,

Éric Florence,

Stefan Eßer,

François Raffi,

Juergen Rockstroh,

Andrea Giacomelli,

Jaime H. Vera,

José I. Bernardino,

Alan Winston,

María Saumoy,

Julien Gras,

Christine Katlama,

Anton Pozniak,

Linos Vandekerckhove,

Els Caluwé,

Stéphane De Wit,

Coca Necsoi,

Maartje Van Frankenhuijsen,

F. Raffi,

Clotilde Allavena,

Véronique Reliquet,

Morane Cavellec,

Audrey Rodallec,

Thierry Le Tourneau,

J. Connault,

JeanMichel Molina,

Samuel Ferret,

Miresta Prévilon,

Yazdan Yazdanpanah,

Roland Landman,

Véronique Joly,

Adriana Pinto Martinez,

Fabienne Caby,

Nadine Ktorza,

Luminita Schneider,

Timo Wolf,

Gundolf Schüttfort,

JanChristian Wasmuth,

Carolynne SchwarzeZander,

Christoph Boesecke,

HansJürgen Stellbrink,

Christian Hoffmann,

Michael Sabranski,

Robert Jablonka,

Heidi Wiehler,

Georg M. N. Behrens,

Matthias Stoll,

Gerrit Ahrenstorf,

Giulia Nardini,

Barbara Beghetto,

Antonella D’Arminio Montforte,

Teresa Bini,

Viola Cogliandro,

Massimo Di Pietro,

Francesco Maria Fusco,

Massimo Galli,

Stefano Rusconi,

Paola Meraviglia,

Ana González-Cordón,

Berta Torres,

Pere Domingo,

Gràcia Mateo,

María Luisa Navarro Gómez,

Joaquin Portillo,

Esperanza Merino,

Sergio Reus,

Vicente Boix,

Félix Gutiérrez,

Sergio Padilla,

Bonaventura Clotet,

Eugènia Negredo,

Anna Bonjoch,

José L. Casado,

Sara Bañón-Escandell,

José Sabán,

Africa Duque,

Daniel Podzamczer,

Laura Acerete,

Juan GonzálezGarcía,

José Ramón Arribas,

Víctor Hontañón,

Nicole Pagani,

Margherita Bracchi,

Amanda Clarke,

Tanya Adams,

Celia Richardson,

Borja Mora-Peris,

Scott Mullaney,

Nahum de Esteban,

Ana Milinkovic,

Sarah Pett,

Juan Tiraboschi,

Mike Youle,

Chloe Orkin,

Simon Rackstraw,

James Hand,

Louise Jennings,

Jane Nicholls,

Sarah Johnston

Publication year - 2018

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciy505

Subject(s) - regimen , dolutegravir , medicine , ritonavir , adverse effect , randomized controlled trial , confidence interval , intention to treat analysis , gastroenterology , viral load , surgery , human immunodeficiency virus (hiv) , immunology , antiretroviral therapy

Both immediate and deferred switching from a ritonavir-boosted protease inhibitor (PI/r)-based regimen to a dolutegravir (DTG)-based regimen may improve lipid profile.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research